Published in J Clin Endocrinol Metab on May 03, 2005
Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest (2008) 2.39
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
Caucasian male infants and boys with hypospadias exhibit reduced anogenital distance. Hum Reprod (2012) 1.64
Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health (2012) 1.40
Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. Int J Androl (2008) 1.31
Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study. Environ Health Perspect (2007) 1.20
Maternal and gestational risk factors for hypospadias. Environ Health Perspect (2008) 1.18
Environmental and genetic contributors to hypospadias: a review of the epidemiologic evidence. Birth Defects Res A Clin Mol Teratol (2012) 1.17
Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia. Mol Endocrinol (2009) 1.12
Impaired reproductive development in sons of women occupationally exposed to pesticides during pregnancy. Environ Health Perspect (2008) 1.01
Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility. Physiol Rev (2016) 0.96
Consensus in Guidelines for Evaluation of DSD by the Texas Children's Hospital Multidisciplinary Gender Medicine Team. Int J Pediatr Endocrinol (2010) 0.91
Endocrine disrupting chemicals: a new and emerging public health problem? Arch Dis Child (2006) 0.87
Associations between congenital cryptorchidism in newborn boys and levels of dioxins and PCBs in placenta. Int J Androl (2011) 0.87
Latin American consensus: children born small for gestational age. BMC Pediatr (2011) 0.82
Parental occupational exposure to endocrine disrupting chemicals and male genital malformations: a study in the Danish National Birth Cohort study. Environ Health (2011) 0.81
Mind the gap: can we explain declining male reproductive health with known antiandrogens? Reproduction (2014) 0.80
Intrauterine growth restriction and hypospadias: is there a connection? Int J Pediatr Endocrinol (2014) 0.80
Ex-premature infant boys with hypospadias are similar in size to age-matched, ex-premature infant boys without hypospadias. J Pediatr Urol (2010) 0.77
Placental Weight and Male Genital Anomalies: A Nationwide Danish Cohort Study. Am J Epidemiol (2016) 0.76
Hormonal profile in children with isolated hypospadias associates better with comprehensive score of local anatomical factors as compared to meatal location or degree of chordee. Indian J Endocrinol Metab (2014) 0.75
Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Biol Sex Differ (2011) 0.75
Influence of maternal diet on the development of malformation of the external genitalia - Are we ready to make some recommendations? Cent European J Urol (2013) 0.75
Evidence for decreasing quality of semen during past 50 years. BMJ (1992) 17.44
Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet (1993) 12.83
Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod (2001) 7.25
Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11
Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology (2012) 3.98
Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet (1998) 3.34
Regional differences in semen quality in Europe. Hum Reprod (2001) 3.19
Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet (2004) 2.69
Possible carcinoma-in-situ of the testis. Lancet (1972) 2.68
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl (1987) 2.61
Semen quality of fertile US males in relation to their mothers' beef consumption during pregnancy. Hum Reprod (2007) 2.26
Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab (1994) 2.21
Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect (1993) 2.09
Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology (1978) 2.07
Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab (2004) 2.02
Nordic consensus on treatment of undescended testes. Acta Paediatr (2007) 1.99
Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab (1997) 1.99
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
A study of finger lengths, semen quality and sex hormones in 360 young men from the general Danish population. Hum Reprod (2005) 1.94
Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab (2003) 1.81
Risk of testicular cancer in subfertile men: case-control study. BMJ (1999) 1.77
Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ (2000) 1.73
High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod (2000) 1.69
Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet (1989) 1.63
Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control (1997) 1.62
Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect (1998) 1.60
Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab (1998) 1.60
Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy. BMJ (1998) 1.57
Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death Differ (2007) 1.55
Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod (2002) 1.55
Spontaneous abortion and physical strain around implantation: a follow-up study of first-pregnancy planners. Epidemiology (2000) 1.54
Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint. Nat Genet (1996) 1.53
Ghrelin inhibits the proliferative activity of immature Leydig cells in vivo and regulates stem cell factor messenger ribonucleic acid expression in rat testis. Endocrinology (2004) 1.52
A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J Biol Chem (1999) 1.51
Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab (1995) 1.51
Adrenocorticotropin and corticotropin-releasing hormone tests in preterm infants. J Clin Endocrinol Metab (2000) 1.50
A follow-up study of environmental and biologic determinants of fertility among 430 Danish first-pregnancy planners: design and methods. Reprod Toxicol (1998) 1.46
Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. J Clin Endocrinol Metab (2012) 1.46
Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology (2005) 1.45
Histological evaluation of the human testis--approaches to optimizing the clinical value of the assessment: mini review. Hum Reprod (2006) 1.44
[Decline in semen quality from 1930 to 1991]. Ugeskr Laeger (1993) 1.43
High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. Mol Hum Reprod (2002) 1.43
Localization of activin receptor (ActR-IIB2) mRNA in the rat seminiferous epithelium. Endocrinology (1993) 1.43
Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology (1999) 1.42
Epidemiology and pathogenesis of cryptorchidism. Hum Reprod Update (2007) 1.42
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene (2007) 1.40
Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer (1999) 1.40
Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control (1996) 1.39
A controlled study on serum insulin-like growth factor-I and urinary excretion of growth hormone in fibromyalgia. J Rheumatol (1995) 1.39
[Hormonal treatment of testicular retention]. Ugeskr Laeger (1991) 1.39
Insulin-like growth factor-I in celiac disease. J Pediatr Gastroenterol Nutr (1994) 1.38
[Deep-freezing of semen from cancer patients--a public task?]. Ugeskr Laeger (1995) 1.37
Risk factors for cryptorchidism and hypospadias. J Urol (1999) 1.36
Exposure to exogenous estrogens in food: possible impact on human development and health. Eur J Endocrinol (1999) 1.35
Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab (1997) 1.33
Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl (1983) 1.32
Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. Int J Androl (2008) 1.31
Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab (1997) 1.30
Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab (1999) 1.29
Testicular development in the complete androgen insensitivity syndrome. J Pathol (2006) 1.29
Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab (1997) 1.27
Carcinoma-in-situ of the undescended testis. Urol Clin North Am (1982) 1.26
Computer-assisted semen analysis parameters as predictors for fertility of men from the general population. The Danish First Pregnancy Planner Study Team. Hum Reprod (2000) 1.26
Testicular cancer risk in boys with maldescended testis: a cohort study. J Urol (1987) 1.25
Pubertal development in Danish children: comparison of recent European and US data. Int J Androl (2006) 1.23
Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab (1995) 1.23
Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr (1997) 1.23
Possible impact of phthalates on infant reproductive health. Int J Androl (2006) 1.22
Female sexual maturation and reproduction after prepubertal exposure to estrogens and endocrine disrupting chemicals: a review of rodent and human data. Mol Cell Endocrinol (2006) 1.20
Sperm morphological defects related to environment, lifestyle and medical history of 1001 male partners of pregnant women from four European cities. Hum Reprod (2001) 1.20
Caffeine intake and fecundability: a follow-up study among 430 Danish couples planning their first pregnancy. Reprod Toxicol (1998) 1.19
Stage-specific expression of nucleoprotein mRNAs during rat and mouse spermiogenesis. Reprod Fertil Dev (1989) 1.19
High incidence of undetected neoplasia in maldescended testes. Lancet (1979) 1.18
Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab (2010) 1.18
Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations. Int J Androl (2007) 1.17
Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest (1995) 1.17
The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) (1994) 1.17
Hypothesis: exposure to endocrine-disrupting chemicals may interfere with timing of puberty. Int J Androl (2010) 1.17